Free Trial
LON:4BB

4basebio (4BB) Share Price, News & Analysis

GBX 1,410
-40.00 (-2.76%)
(As of 09/6/2024 11:37 AM ET)
Today's Range
1,400
1,410
50-Day Range
1,288.40
1,599
52-Week Range
492
1,820
Volume
1,080 shs
Average Volume
2,666 shs
Market Capitalization
£180.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 4basebio

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

4BB Stock Price History

4BB Stock News Headlines

Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
4basebio Plc - Exercise of Options and Issue of Equity
4basebio Plc - Half-year Report
4basebio Plc - Research Collaboration
4basebio Plc - Result of AGM
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
4basebio Plc - Director/PDMR Shareholding
4BASEBIO UK SOCIETAS (4BB)
See More Headlines
Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Net Income
£-7,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£311,000.00
Cash Flow
GBX 87.69 per share
Book Value
GBX (4) per share

Miscellaneous

Free Float
N/A
Market Cap
£180.62 million
Optionable
Not Optionable
Beta
1.12
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Heikki Lanckriet Ph.D. (Age 47)
    CEO, Chief Scientific Officer & Executive Director
    Comp: $448.9k
  • Mr. David Roth (Age 57)
    CFO, Company Secretary & Executive Director
    Comp: $323.1k
  • Mr. Mark Cooper
    Head of Manufacturing

4BB Stock Analysis - Frequently Asked Questions

How have 4BB shares performed this year?

4basebio's stock was trading at GBX 680 at the start of the year. Since then, 4BB stock has increased by 107.4% and is now trading at GBX 1,410.
View the best growth stocks for 2024 here
.

How do I buy shares of 4basebio?

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:4BB) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners